Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Santa Rosa
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Santa Rosa, CA

Studies commonly pay $75 to $4,500 per completed study

147 clinical trials are currently recruiting participants within 30 miles of Santa Rosa. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

147studies recruiting
8+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Santa Rosa right now

Top 25 of 147 recruiting studies, sorted by proximity — each links to its official registry page

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Santa Rosa, California (0.6 mi) · Sponsor: AstraZeneca

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

Primary Open Angle Glaucoma Phase 3 Interventional 130 participants sought
North Bay Eye Associates /ID# 277071 — Petaluma, California (15.2 mi) · Sponsor: AbbVie

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Phase 2 Interventional 146 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Providence Medical Foundation ( Site 9543) — Santa Rosa, California (0.6 mi) · Sponsor: Merck Sharp & Dohme LLC

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction Phase 3 Interventional 5,056 participants sought
NorthBay Clinical Research LLC — Santa Rosa, California (0.6 mi) · Sponsor: Amgen

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Solid Tumor, Non-Small Cell Lung Cancer Phase 1, Phase 2 Interventional 340 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Inhibrx Biosciences, Inc

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Colorectal Cancer Stage II, Colorectal Cancer Stage III Phase 3 Interventional 1,057 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Prostate Cancer, Metastatic Castration Resistant Prostate Cancer Phase 1 Interventional 174 participants sought
Providence Medical Group Oncology Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Astellas Pharma Global Development, Inc.

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Small Cell Lung Cancer Extensive Stage Phase 1, Phase 2 Interventional 170 participants sought
Providence Medical Foundation ( Site 0124) — Santa Rosa, California (0.6 mi) · Sponsor: Merck Sharp & Dohme LLC

SELUTION4BTK Trial

Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities N/A Interventional 376 participants sought
St. Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: M.A. Med Alliance S.A.

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Colorectal Cancer, CRC (Colorectal Cancer) Phase 2 Interventional 136 participants sought
NGM Clinical Study Site — Santa Rosa, California (0.6 mi) · Sponsor: NGM Biopharmaceuticals, Inc

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Hodgkin Lymphoma, Non-Hodgkin Lymphoma N/A Observational 2,000 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Phase 2 Interventional 156 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)
Actively enrolling

Studies you may be able to join near Santa Rosa

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Santa Rosa

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Providence Medical Group Santa Rosa - Clinical Trials

3555 Round Barn Cir, Santa Rosa, CA 95403
(707) 521-3830

Siyan Clinical Corporation

★ 4.8 (564 reviews)
480 Tesconi Cir Ste B, Santa Rosa, CA 95401
(707) 206-7268

TrueNorth Health Center

★ 4.4
1551 Pacific Ave, Santa Rosa, CA 95404
(707) 586-5555

Santa Rosa Behavioral Healthcare Hospital

★ 2.2 (244 reviews)
1287 Fulton Rd, Santa Rosa, CA 95401
(707) 800-7700
"Everyone that works there (except for the kitchen staff) knows how to treat people and do their best even when others (patience) are not trying to he…"
— Lamar Manuel, 5★

Sunwise Clinical Research

★ 4.7
1371 Oakland Blvd #301, Walnut Creek, CA 94596
(925) 298-5147
"They are a great group of people"
— Tree Sap, 5★

Evolve Restorative Center

★ 4.1 (53 reviews)
220 Concourse Blvd, Santa Rosa, CA 95403
(844) 527-7369
"First time I've been to this practice....and it will be my last. Looks like a nice facility but staff are robotic and appear to care less about thei…"
— Mike Antill, 1★

Oakland Clinical

3300 Webster St #1106, Oakland, CA 94609
(510) 817-2000

CPMC Research Institute

★ 5.0
2330 Clay St, San Francisco, CA 94115
(415) 561-1785

Clinical trials in Santa Rosa: what's recruiting

The Santa Rosa area currently has 147 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Santa Rosa, the most active research areas are:

  • Cancer & Oncology20 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Santa Rosa, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Santa Rosa

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Santa Rosa participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Santa Rosa pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Santa Rosa safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Santa Rosa, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Santa Rosa?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Santa Rosa typically complete one or two studies per year.

Paid clinical trials near Santa Rosa

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of CA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts